Taking the question as asked, rather than the general version of it. The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value. One out-of-range result in isolation generates anxiety and unnecessary tests; the same result next to the trend and the rest of the panel usually generates a shrug.
I got a full panel before starting and a repeat at three months, and the second one is more useful than the first purely because I now have something to compare against.
The narrow version of the question is what actually belongs on a baseline panel, as opposed to the enormous list that gets pasted around here.
I would rather have one careful answer than five confident ones.
BethLabQueen said:The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value.
BethLabQueen has the substance of this right. The condition it depends on is worth stating. One addition: if the lab changes analytical platform between your draws, the comparison breaks and nobody tells you. It is worth asking when a value moves inexplicably.
PeptideMeter — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsDataDave said:I got a full panel before starting and a repeat at three months, and the second one is more useful than the first purely because I now have something…
Same position here, arrived at the long way round. Quarterly for the first year is convention rather than evidence, and it is defensible for a simple reason: it is roughly the interval over which HbA1c becomes informative again, since it reflects about three months of glycaemia. After the first year, and once doses are stable, annual is reasonable unless something specific is being followed.
Happy to go further on any of that.
Adding the clinical framing, because it changes how the question reads.
Shot day Thursday report relevant to baseline bloodwork:
Week 16. Currently on 1.7mg. Down 62 lbs from starting weight of 274 lbs.
This week's observations: Energy levels excellent, zero nausea.
Labs due next week — looking forward to seeing the metabolic panel. I'll post results in the Lab Results section when they come in.
Amazing transformation! Starting at 287 lbs, I'm now at 162 lbs after 18 months on semaglutide 2.4mg/wk. These photos show my progress at months 3, 6, 9, 12, 15, and 18. The body recomposition has been incredible — DEXA shows 23% body fat, down from 42%...